NO934218L - Inhibitorer av cathepsin g og elastase for forhindring av bindevevsned-brytning - Google Patents

Inhibitorer av cathepsin g og elastase for forhindring av bindevevsned-brytning

Info

Publication number
NO934218L
NO934218L NO934218A NO934218A NO934218L NO 934218 L NO934218 L NO 934218L NO 934218 A NO934218 A NO 934218A NO 934218 A NO934218 A NO 934218A NO 934218 L NO934218 L NO 934218L
Authority
NO
Norway
Prior art keywords
cathepsin
connective tissue
elastase
inhibitors
tissue degradation
Prior art date
Application number
NO934218A
Other languages
English (en)
Other versions
NO934218D0 (no
Inventor
Michael R Angelastro
Philippe Bey
Niall S Doherty
Michael J Janusz
Shujaath Mehdi
Norton P Peet
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO934218L publication Critical patent/NO934218L/no
Publication of NO934218D0 publication Critical patent/NO934218D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Vehicle Body Suspensions (AREA)
  • Polymerisation Methods In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transceivers (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Dental Preparations (AREA)
NO934218A 1991-05-23 1993-11-22 Inhibitorer av cathepsin G og elastase for forhindring avbindevevsnedbrytning NO934218D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70449991A 1991-05-23 1991-05-23
PCT/US1992/003288 WO1992020357A1 (en) 1991-05-23 1992-04-21 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation

Publications (2)

Publication Number Publication Date
NO934218L true NO934218L (no) 1993-11-22
NO934218D0 NO934218D0 (no) 1993-11-22

Family

ID=24829789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934218A NO934218D0 (no) 1991-05-23 1993-11-22 Inhibitorer av cathepsin G og elastase for forhindring avbindevevsnedbrytning

Country Status (17)

Country Link
US (1) US5510333A (no)
EP (1) EP0587799B1 (no)
JP (1) JP3442075B2 (no)
AT (1) ATE181925T1 (no)
AU (1) AU655301B2 (no)
DE (1) DE69229552T2 (no)
DK (1) DK0587799T3 (no)
ES (1) ES2136091T3 (no)
FI (1) FI935172A (no)
GR (1) GR3031005T3 (no)
HU (1) HU217612B (no)
IL (1) IL101925A (no)
NO (1) NO934218D0 (no)
NZ (1) NZ242807A (no)
PT (1) PT100517B (no)
WO (1) WO1992020357A1 (no)
ZA (1) ZA923602B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
WO1993021221A1 (en) * 1992-04-10 1993-10-28 Abbott Laboratories Pulmonary surfactant protein fragments
CA2137832C (en) * 1992-06-12 2000-09-26 Dennis J. Hoover Inhibitors of angiotensin i chymase(s) including human heart chymase
KR100367389B1 (ko) * 1994-06-02 2003-07-18 메렐 파마슈티칼스 인크. 엘라스타제억제제의프로드러그로서아실화에놀유도체
DK0763055T3 (da) * 1994-06-02 2000-05-08 Merrell Pharma Inc Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5693515A (en) * 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
DE19543750C2 (de) * 1995-11-24 1997-10-23 Crinos Industria Farmaco Cathepsin G inhibierende Aptamere
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
ATE255126T1 (de) * 1996-04-22 2003-12-15 Massachusetts Inst Technology Unterdrückung von immunantwort durch hemmung von cathepsin s
JP2002047256A (ja) * 2000-07-26 2002-02-12 Kanegafuchi Chem Ind Co Ltd α−アミノ−α´，α´，α´−トリハロケトン誘導体、α−アミノ−α´，α´，α´−トリハロアルコ−ル誘導体、及び、α−ヒドロキシ−β−アミノカルボン酸誘導体の製造法
WO2008054144A1 (en) * 2006-11-03 2008-05-08 Amorepacific Corporation Skin external composition containing cathepsin g inhibitors for preventing skin aging and the screening method for development of antiaging materials
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
US20220354833A1 (en) 2019-09-17 2022-11-10 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
WO2021209739A1 (en) 2020-04-16 2021-10-21 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
CN116096714A (zh) 2020-06-10 2023-05-09 安力高医药股份有限公司 用于治疗冠状病毒、小核糖核酸病毒和诺罗病毒感染的抗病毒化合物
WO2023283256A1 (en) 2021-07-09 2023-01-12 Aligos Therapeutics, Inc. Anti-viral compounds
TW202325294A (zh) 2021-10-20 2023-07-01 英商梅瑞奧生物製藥４有限公司 用於治療纖維化之嗜中性球彈性蛋白酶抑制劑

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230275A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Elastaseinhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
EP0307662A3 (en) * 1987-08-24 1990-07-25 Kabushiki Kaisha Vitamin Kenkyusyo Enkephalin analogs
EP0356595A1 (en) * 1988-09-01 1990-03-07 Merrell Dow Pharmaceuticals Inc. Novel peptidase inhibitors
ZA897515B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
DE3938971A1 (de) * 1989-11-24 1991-05-29 Biotechnolog Forschung Gmbh Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat

Also Published As

Publication number Publication date
WO1992020357A1 (en) 1992-11-26
AU2184192A (en) 1992-12-30
ATE181925T1 (de) 1999-07-15
HUT65140A (en) 1994-04-28
DK0587799T3 (da) 1999-11-22
US5510333A (en) 1996-04-23
AU655301B2 (en) 1994-12-15
ZA923602B (en) 1993-02-24
HU217612B (hu) 2000-03-28
IL101925A (en) 1996-03-31
EP0587799A4 (en) 1995-06-14
ES2136091T3 (es) 1999-11-16
FI935172A0 (fi) 1993-11-22
GR3031005T3 (en) 1999-12-31
NO934218D0 (no) 1993-11-22
EP0587799B1 (en) 1999-07-07
IL101925A0 (en) 1992-12-30
HU9303314D0 (en) 1994-03-28
PT100517A (pt) 1993-09-30
EP0587799A1 (en) 1994-03-23
DE69229552T2 (de) 1999-12-23
NZ242807A (en) 1994-07-26
JP3442075B2 (ja) 2003-09-02
FI935172A (fi) 1993-11-22
PT100517B (pt) 1999-06-30
JPH06508355A (ja) 1994-09-22
DE69229552D1 (de) 1999-08-12

Similar Documents

Publication Publication Date Title
NO934218D0 (no) Inhibitorer av cathepsin G og elastase for forhindring avbindevevsnedbrytning
ATE193304T1 (de) Inhibitoren der menschlichen neutrophilenelastase
DK0529568T3 (da) Nye oralt aktive elastaseinhibitorer
ATE199090T1 (de) Gegenüber eigenen inhibitoren resistente t-pa mutanten
NO942549D0 (no) Humanproteaseinhibitorvariant av Kunitz-type
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DK0804465T3 (da) Nye elastaseinhibitorer
EA199800200A1 (ru) Ингибиторы пролилэндопептидазы
AR021241A1 (es) Inhibidores de proteasas
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
PT666755E (pt) Inibicao da infeccao pelo vih
CA2109516A1 (en) Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
HUP9902417A2 (hu) Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai
ECSP951559A (es) Inhibidores de la 5- lipoxigenasa
KR940027038U (ko) 압축기의 소음기

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application